Dr. Hoshida on Molecular Subtyping in HCC

Video

Yujin Hoshida, MD, PhD, discusses molecular subtyping in hepatocellular carcinoma.

Yujin Hoshida, MD, PhD, associate professor of internal medicine, University of Texas Southwestern Medical Center, discusses molecular subtyping in hepatocellular carcinoma (HCC).

Over the past decade, multiple subtypes of HCC have been identified using advanced genomic technology, says Hoshida. The research suggests that there may be a link between how patients with different molecular subtypes of HCC respond to different therapeutic options, explains Hoshida.

Understanding what patient subtype responds best to what treatment may be a more efficient way to personalize therapy rather than to direct specific drugs to multiple targets, concludes Hoshida.

Related Videos
Ilyas Sahin, MD
Patrick I. Borgen, MD
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Reshma Lillaney Mahtani, DO
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania